Detalhe da pesquisa
1.
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes.
Haematologica
; 108(2): 532-542, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979720
2.
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation.
Eur J Haematol
; 110(6): 633-638, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788756
3.
A young woman with persistent sore throat, Epstein-Barr virus, lymphadenopathy, and aberrant CD4 + CD7- T-cells.
Am J Hematol
; 98(5): 824-829, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606704
4.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122325
5.
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Br J Haematol
; 181(6): 782-790, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741758
6.
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Blood
; 127(24): 3082-91, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020088
7.
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysis.
Br J Haematol
; 179(1): 83-97, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28677895
8.
VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome).
Haematologica
; 107(4): 1011-1013, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911285
9.
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
Ann Hematol
; 96(12): 2025-2029, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28975386
10.
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Am J Hematol
; 92(10): 1037-1046, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675513
11.
Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome.
CMAJ
; 194(14): E524-E527, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35410861
12.
Majocchi's granuloma in a patient with GATA2 haploinsufficiency undergoing hematopoietic stem cell transplantation.
Transpl Infect Dis
; 24(1): e13764, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793614
13.
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study.
Br J Haematol
; 174(1): 88-101, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26991631
14.
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Biol Blood Marrow Transplant
; 21(8): 1437-44, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865648
15.
Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome.
Haematologica
; 98(3): 409-13, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22929976
16.
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Br J Haematol
; 158(2): 174-185, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22640008
17.
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(5): 639-46, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20005967
18.
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biol Blood Marrow Transplant
; 15(2): 205-13, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167680
19.
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS.
Leuk Res
; 74: 21-41, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286330
20.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Clin Lymphoma Myeloma Leuk
; 18(11): e481-e491, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100330